Skip to content
Tuesday, November 10, 2026
Explore cutting-edge insights on tech trends, digital innov…

Giving Stem Cells During Pregnancy to Babies with Spina Bifida Boosts Quality of Life, Study Reveals

A pioneering research effort has found that providing pluripotent cells to developing infants diagnosed with spina bifida during corrective surgery can be a "significant breakthrough" in managing prenatal disorders.

Research Framework and Assurance

The American study focused on six fetuses with the 'open' form of spina bifida. Doctors administered mother's placental stem cells directly onto the infant's spine while the defect was being closed.

Critically, the stem cell application was found to be safe. Researchers confirmed that the treatment did not lead to tumors, disrupt the healing process, or block the correction of related neurological issues.

Positive Developments

Post-birth MRI scans showed a successful correction of hindbrain herniation in each of the babies. This brain structure normalization is strongly associated with better mobility and function.

"If it makes additional babies able to walk who wouldn't have, it could establish itself as the conventional approach," said the lead researcher. "The outcomes appear super exciting and pave the way for a variety of prospective novel therapies."

Long-Term Prospects and Optimism

Experts not involved in the trial indicated that additional validation of these apparent benefits could signal a "new era" in in-utero treatment. The prospect of enhancing nerve function impairment seen in utero is considered a transformative goal.

Notably important would be better management of urogenital and gastrointestinal outcomes, which are typical difficulties for people affected by this condition.

Future Directions

Although this preliminary study was small in scale, its confirmed tolerability and hopeful trends offer a robust platform for larger, more comprehensive studies. The combination of regenerative medicine with established fetal surgery techniques presents significant potential for transforming outcomes for future generations with spina bifida.

About the author

Joshua Doyle

A tech journalist and innovation enthusiast with over a decade of experience covering emerging technologies and digital transformation across Europe.

Hub Modern Blog UK

Type to search articles.